- Biologic treatment in glomerular disease2014 | 1. lékařská fakulta
- Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases2021 | 1. lékařská fakulta
- Nemoci glomerolů.1998 | Fakulta tělesné výchovy a sportu
- Možnosti použití biologické léčby u nemocných s glomerulárními chorobami2012 | 1. lékařská fakulta
- Možnosti použití rituximabu v léčbě nemocných s glomerulárními chorobami2011 | 1. lékařská fakulta
- Certain Cytokines and Their Possible Role in the Pathogenesis of Glomerular Diseases in Children1998 | Lékařská fakulta v Hradci Králové
- Prevalence hypertenze u glomerulopatií-informace z Českého registru renálních biopsií2004 | 1. lékařská fakulta
- Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy2023 | 1. lékařská fakulta
- Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments2014 | 1. lékařská fakulta
- Screening for NPHS2 Mutations May Help Predict FSGS Recurrence after Transplantation2011 | 2. lékařská fakulta
- Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children2017 | 2. lékařská fakulta
- Genotype/Phenotype Correlation in Nephrotic Syndrome Caused by WT1 Mutations2010 | 2. lékařská fakulta
- Incidence of arterial hypertension in different types of glomerulopathies in the Czech Registry of renal biopsies (CRRP) in the years 1995-20022004 | 1. lékařská fakulta
- Diabetic nephropathy2011 | 3. lékařská fakulta
- Chapter 22 Diabetic Nephropathy2016 | 3. lékařská fakulta
- Heart Tumor in a Girl with Nephrotic Syndrome, a Possible Association or a Rare Coincidence?2024 | 2. lékařská fakulta
- Novinky v diagnostice a léčbě glomerulonefritidy2013 | 1. lékařská fakulta
- Sparsentan. Dual angiotensin II AT1 receptor blocker and endothelin ETA receptor antagonist, Treatment of focal segmental glomerulosclerosis, Treatment of IgA nephropathy2020 | 1. lékařská fakulta
- Complement Inhibition in ANCA-Associated Vasculitis2022 | 1. lékařská fakulta
- Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children2019 | 2. lékařská fakulta
- The management of membranous nephropathy-an update2022 | 1. lékařská fakulta
- Indication for corticosteroids in IgA nephropathy: validation in the European VALIGA cohort of a treatment score based on the Oxford classification2022 | 1. lékařská fakulta
- Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: Early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis2016 | 2. lékařská fakulta, Lékařská fakulta v Plzni
- Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome2023 | 1. lékařská fakulta
- Renal Biopsy in 2015-From Epidemiology to Evidence-Based Indications2016 | 1. lékařská fakulta
- Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives2022 | 1. lékařská fakulta
- Molecular Profiling in IgA Nephropathy and Focal and Segmental Glomerulosclerosis2018 | 1. lékařská fakulta, Ústřední knihovna
- Estimating Time to ESRD in Children With CKD2018 | 2. lékařská fakulta